T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

NCT00433407 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Sarcoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: trastuzumab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]